Universe Pharmaceuticals Inc
NASDAQ:UPC
Cash Flow Statement
Cash Flow Statement
Universe Pharmaceuticals Inc
| Sep-2020 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||
| Net Income |
8
|
11
|
13
|
(9)
|
(11)
|
(6)
|
(19)
|
(9)
|
1
|
(4)
|
|
| Depreciation & Amortization |
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
|
| Change in Deffered Taxes |
(0)
|
(1)
|
(1)
|
(1)
|
0
|
1
|
1
|
1
|
(0)
|
0
|
|
| Other Non-Cash Items |
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
7
|
0
|
(7)
|
0
|
|
| Cash Taxes Paid |
2
|
3
|
5
|
3
|
1
|
1
|
1
|
0
|
(1)
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(2)
|
(13)
|
(9)
|
7
|
8
|
7
|
4
|
(2)
|
(6)
|
(2)
|
|
| Cash from Operating Activities |
6
N/A
|
(2)
N/A
|
4
N/A
|
(1)
N/A
|
(3)
-101%
|
1
N/A
|
(6)
N/A
|
(10)
-56%
|
(12)
-22%
|
(5)
+57%
|
|
| Investing Cash Flow | |||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
(27)
|
(27)
|
(4)
|
(4)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(27)
-54 020%
|
(27)
0%
|
(4)
+86%
|
(4)
+2%
|
(0)
+99%
|
(0)
-144%
|
(0)
-235%
|
(0)
-18%
|
(0)
+20%
|
|
| Financing Cash Flow | |||||||||||
| Net Issuance of Common Stock |
0
|
29
|
29
|
0
|
0
|
0
|
0
|
25
|
40
|
15
|
|
| Net Issuance of Debt |
1
|
1
|
1
|
3
|
5
|
(1)
|
3
|
9
|
4
|
(5)
|
|
| Other |
(0)
|
(3)
|
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
0
N/A
|
27
+5 555%
|
27
0%
|
3
-88%
|
5
+63%
|
(1)
N/A
|
3
N/A
|
34
+1 207%
|
44
+30%
|
10
-78%
|
|
| Change in Cash | |||||||||||
| Effect of Foreign Exchange Rates |
0
|
1
|
1
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(1)
|
(0)
|
|
| Net Change in Cash |
7
N/A
|
(2)
N/A
|
4
N/A
|
(2)
N/A
|
(1)
+46%
|
(0)
+67%
|
(4)
-858%
|
24
N/A
|
31
+29%
|
4
-87%
|
|
| Free Cash Flow | |||||||||||
| Free Cash Flow |
6
N/A
|
(3)
N/A
|
4
N/A
|
(1)
N/A
|
(3)
-90%
|
1
N/A
|
(6)
N/A
|
(10)
-59%
|
(12)
-22%
|
(5)
+55%
|
|